The pharmaceutical company plans to expedite the delivery of the co-vaccine by the end of May, two weeks before the mutual agreement.
New York, April 13 (EFE). -executive director Pfizer, Albert Bourla assured the outside world on Tuesday that the pharmaceutical company will be able to deliver to the United States in May United States 10% greater than the dose COVID-19 vaccine He had promised to achieve the goal.
Burla said in an unusual message sent through his Twitter account that Pfizer has increased the production of the product vaccine.
According to executives, the company will deliver 220 million doses It has promised to hand it over to the US government, and by the end of July, it will complete a total dose of 300 million doses.
Burla emphasized that the order will be ready Two weeks ago Reach an agreement.
The announcement came on the same day that the U.S. government proposed to suspend the patent application. Vacuum cleaner After finding 6 cases, targeting covid-19 Cerebral thrombosis There were six women, one of whom died and the other was in serious condition.
After federal health authorities advised him to conduct investigations across the United States, his administration has been suspended. time out “Just in case”, these cases were thoroughly investigated at the same time.
This Unfavorable situation They were found in six women between the ages of 18 and 48, and they were all developed within one to three weeks after vaccination.
This Biological Assessment and Research Center From Food and Drug Administration (FDA), responsible for approving COVID-19 vaccine In the country, he pointed out: “These cases seem to be extremely rare.”
However, according to local media reports, these side effects are not on the list of possible reactions listed in the emergency use of Johnson & Johnson vaccine. EFE
Don’t miss the latest news from Live Usa on Google News, Follow us here